Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.

About this trial

Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Multiple Sclerosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Multiple Sclerosis patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participant has a diagnosis of Multiple Sclerosis

Patient has self-identified as planning to enroll in an interventional clinical trial for Multiple Sclerosis

Patient is at least 18 years of age

Disqualifiers

Inability to perform regular electronic reporting

Patient does not understand, sign, and return consent form

No diagnosis of Multiple Sclerosis confirmed

Trial population

Multiple Sclerosis patients who are actively considering involvement in an interventional clinical trial, but have not yet completed enrollment and registration.

Trial design

Design model

Case-crossover

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Rate of patients who decide to enroll in a Multiple Sclerosis Clinical Trial

Time frame
3 months
2

Number of patients who remain in Multiple Sclerosis clinical trial until completion

Time frame
12 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: